TAS2R1 Antibody

What is TAS2R1 and what is its primary biological function?

TAS2R1 (Taste Receptor Type 2 Member 1) is a G protein-coupled receptor that primarily functions as a bitter taste receptor. It plays a significant role in the perception of bitterness and is gustducin-linked. Beyond taste perception, TAS2R1 may serve important roles in sensing the chemical composition of gastrointestinal content. At the molecular level, the activity of this receptor can stimulate alpha gustducin, mediate PLC-beta-2 activation, and lead to the gating of TRPM5 . Research indicates that taste receptors like TAS2R1 are distributed beyond the taste buds and may have physiological roles in multiple organ systems .

What applications are TAS2R1 antibodies commonly used for in laboratory research?

TAS2R1 antibodies are primarily used in several research applications:

• Western Blotting (WB): For detecting TAS2R1 protein expression in tissue/cell lysates, typically at dilutions of 1:500-1:2000

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of TAS2R1, often at dilutions of 1:20000

• Immunohistochemistry (IHC): For visualizing the cellular and tissue localization of TAS2R1, typically at dilutions of 1:50-1:300

• Immunofluorescence (IF): For co-localization studies with other cellular markers

The optimal working concentration varies across applications and should be determined experimentally by each researcher .

What is the observed versus calculated molecular weight of TAS2R1, and why might they differ?

The calculated molecular weight of TAS2R1 is approximately 34.3 kDa, while the observed molecular weight in Western blot analyses is often reported as approximately 72 kDa . This discrepancy is common with membrane proteins like TAS2R1 and may be attributed to:

• Post-translational modifications (glycosylation, phosphorylation)

• Protein-protein interactions or dimerization

• The hydrophobic nature of transmembrane proteins affecting migration in SDS-PAGE

• Incomplete denaturation during sample preparation

Researchers should be aware of this difference when interpreting Western blot results to avoid misidentification of the target protein .

What are the optimal fixation and permeabilization methods for immunocytochemistry with TAS2R1 antibodies?

For immunocytochemistry applications with TAS2R1 antibodies, research indicates:

• Fixation: 4% paraformaldehyde (PFA) for 15-20 minutes at room temperature is commonly used

• Permeabilization: This step is critical as demonstrated in studies where certain TAS2R receptors (like TAS2R102 and TAS2R131) were only visible after cell permeabilization

The permeabilization step typically involves:

• 0.1-0.2% Triton X-100 for 10 minutes at room temperature

• Alternative: 0.5% saponin can be used for more gentle permeabilization

Importantly, researchers should note that the requirement for permeabilization varies; some TAS2R receptors (including TAS2R106, TAS2R118, and TAS2R134) exhibit clear cell surface staining even in unpermeabilized cells . Therefore, comparison of staining in permeabilized versus unpermeabilized cells can provide valuable information about receptor trafficking and localization.

How should researchers validate the specificity of TAS2R1 antibodies before experimental use?

Rigorous validation of TAS2R1 antibodies should include multiple approaches:

• Positive and negative controls:

  • Positive control: Tissues/cells known to express TAS2R1 (e.g., taste buds, specific cell lines)

  • Negative control: Omission of primary antibody

  • Competitive inhibition with immunizing peptide

• Cross-reactivity testing:

  • Testing reactivity against related TAS2R family members

  • Heterologous expression systems (as used for TAS2R43/31 antibody specificity testing in transiently transfected HEK293 cells)

• Multiple detection methods:

  • Combining immunocytochemistry with flow cytometry verification

  • Correlating protein detection with mRNA expression data from RT-qPCR

• Western blot analysis:

  • Confirming single band at expected molecular weight

  • Testing in multiple relevant tissues/cell types

Proper validation ensures experimental results are attributable to the target protein rather than non-specific binding.

What storage and handling protocols maximize TAS2R1 antibody stability and performance?

To maintain optimal TAS2R1 antibody performance:

• Long-term storage:

  • Store at -20°C for up to one year

  • Avoid repeated freeze-thaw cycles by preparing small aliquots upon receipt

• Short-term storage:

  • For frequent use, store at 4°C for up to one month

• Working solution preparation:

  • Dilute in appropriate buffer immediately before use

  • Many TAS2R1 antibodies are supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

• Quality control:

  • Periodically validate antibody performance with positive controls

  • Monitor for changes in signal intensity or background over time

Following these protocols helps ensure reproducible results across experiments and maximizes the usable lifespan of the antibody.

How can TAS2R1 antibodies be used to investigate receptor trafficking and membrane localization?

Advanced investigations of TAS2R1 trafficking can employ:

• Differential permeabilization techniques:

  • Compare staining patterns in permeabilized versus unpermeabilized cells to distinguish between surface-expressed and internally retained receptors

  • Research shows some receptors (TAS2R102, TAS2R131) were only visible after permeabilization, while others (TAS2R106, TAS2R118, TAS2R134) showed clear cell surface staining in unpermeabilized cells

• Dual-color immunofluorescence:

  • Co-staining with markers for subcellular compartments (ER, Golgi, endosomes)

  • Use of N-terminal versus C-terminal directed antibodies to assess receptor orientation

• Live-cell imaging approaches:

  • Pulse-chase experiments with antibodies against extracellular epitopes

  • TIRF microscopy to visualize membrane-proximal receptors

• Biochemical fractionation:

  • Separation of membrane and cytosolic fractions followed by Western blotting

  • Surface biotinylation assays to quantify plasma membrane expression

These approaches can reveal mechanisms of receptor trafficking defects that might prevent functional identification of agonists for certain TAS2R receptors .

What strategies can resolve contradictory results between mRNA expression and protein detection of TAS2R1?

When facing discrepancies between TAS2R1 mRNA and protein detection:

• Technical considerations:

  • Verify antibody specificity through knockout/knockdown controls

  • Compare multiple antibodies targeting different epitopes

  • Assess sensitivity limits of protein versus mRNA detection methods

• Biological explanations to investigate:

  • Post-transcriptional regulation through microRNAs or RNA-binding proteins

  • Protein stability and turnover rates

  • Translational efficiency differences

• Methodological approaches:

  • Correlate qRT-PCR data with in situ hybridization results, as demonstrated in mouse taste receptor studies where receptors showing strong expression in qRT-PCR (like Tas2r118) also exhibited pronounced staining in in situ hybridization

  • Combine with ribosome profiling to assess translation efficiency

  • Employ protein degradation inhibitors to assess turnover rates

• Cell-specific expression analysis:

  • Single-cell RNA-seq compared with immunohistochemistry

  • Laser capture microdissection of specific cell populations

Understanding these discrepancies may reveal important regulatory mechanisms governing TAS2R1 expression.

How can researchers assess the functional impact of genetic variations in TAS2R1?

To evaluate the functional consequences of TAS2R1 genetic variants:

• Computational prediction approaches:

  • Tools like PolyPhen-2 and SIFT can predict functional effects of nonsynonymous substitutions

  • Research has identified numerous SNPs with potential functional impacts on TAS2R receptors, including variants predicted to be "Possibly or Probably Damaging" or "Deleterious"

• In vitro functional assays:

  • Calcium imaging to measure receptor activation

  • cAMP accumulation assays

  • β-arrestin recruitment

• Cell surface expression analysis:

  • Compare wild-type versus variant receptor trafficking using antibodies

  • ELISA-based quantification of surface expression

• Structure-function relationship studies:

  • Use site-directed mutagenesis to introduce specific variations

  • Compare responses to a panel of bitter compounds between wild-type and variant receptors

• Population genetics approach:

  • Correlate specific variants with phenotypic differences in taste perception

  • Analyze evolutionary conservation across species

This multi-faceted approach provides comprehensive insight into how genetic variations affect TAS2R1 function and potential physiological consequences.

What are the key differences between human and mouse TAS2R receptor systems that researchers should consider?

When designing cross-species studies of TAS2R receptors:

These differences highlight the need for caution when extrapolating findings between species in taste receptor research.

What methodological adaptations are necessary when using TAS2R1 antibodies across different species?

When applying TAS2R1 antibodies across species:

• Epitope sequence verification:

  • Compare the immunogen sequence (often human TAS2R1 AA 6-55 or similar regions) with corresponding sequences in target species

  • Higher sequence homology suggests better cross-reactivity

• Validation in each species:

  • Perform Western blots on tissue from each species to confirm appropriate band size

  • Include species-specific positive controls (tissues known to express TAS2R1)

  • Consider testing multiple antibodies raised against different epitopes

• Protocol optimization:

  • Adjust antibody concentrations, incubation times, and buffer conditions for each species

  • Modify antigen retrieval methods for fixed tissues based on species-specific tissue composition

• Controls for interpretation:

  • Include knockout/knockdown controls when available

  • Compare immunostaining patterns with published expression data in each species

  • Use RNA expression analysis as complementary evidence

Thorough validation in each species ensures reliable cross-species comparisons and prevents misinterpretation of experimental results.

What are the most common causes of false positive or negative results when using TAS2R1 antibodies, and how can they be addressed?

Common issues and solutions when working with TAS2R1 antibodies include:

False Negatives:

• Insufficient antigen retrieval:

  • Optimize antigen retrieval methods (heat-induced vs. enzymatic)

  • Adjust pH of retrieval buffer (citrate vs. EDTA-based)

• Inadequate cell permeabilization:

  • Research shows some TAS2R receptors are only visible after permeabilization

  • Test different permeabilization reagents and times

• Low receptor expression:

  • Increase antibody concentration or incubation time

  • Use signal amplification methods (e.g., tyramide signal amplification)

  • Consider more sensitive detection methods

False Positives:

• Non-specific binding:

  • Include appropriate blocking steps (5-10% normal serum from secondary antibody species)

  • Test antibody specificity with immunizing peptide competition

  • Use knockout/knockdown controls when available

• Cross-reactivity with related receptors:

  • Validate with heterologous expression systems

  • Compare staining patterns with mRNA expression data

• Autofluorescence issues:

  • Include unstained controls

  • Use Sudan Black B to reduce autofluorescence

  • Consider spectral unmixing during image acquisition

Methodological controls such as omission of primary antibody and immunizing peptide competition are essential for distinguishing specific from non-specific signals.

How can researchers optimize Western blotting protocols for detecting TAS2R1 in different tissue types?

For optimal Western blot detection of TAS2R1 across diverse tissues:

• Sample preparation considerations:

  • Use specialized membrane protein extraction buffers containing 1-2% detergent (Triton X-100, NP-40, or CHAPS)

  • Avoid boiling samples (heat to 37-50°C instead) to prevent membrane protein aggregation

  • Include protease inhibitors to prevent degradation

• Gel and transfer optimizations:

  • Use gradient gels (4-12% or 4-20%) for better resolution of membrane proteins

  • Consider wet transfer methods for more efficient transfer of hydrophobic proteins

  • Add 0.05-0.1% SDS to transfer buffer to improve membrane protein transfer

• Tissue-specific adaptations:

  • For tissues with high fat content (e.g., tongue epithelium), incorporate additional delipidation steps

  • For tissues with low TAS2R1 expression, increase total protein loading or use immunoprecipitation to concentrate the target

• Detection strategies:

  • Use high-sensitivity chemiluminescent substrates for low-abundance targets

  • Consider fluorescent secondary antibodies for more accurate quantification

  • Recommended antibody dilutions range from 1:500-1:2000 for Western blotting

• Controls and validation:

  • Include positive control lysates from tissues known to express TAS2R1

  • Verify band specificity with blocking peptide competition

  • Be aware that the observed molecular weight (~72 kDa) may differ from the calculated weight (~34 kDa)

These optimizations can improve detection sensitivity and specificity across different experimental contexts.

What strategies can researchers employ to minimize batch-to-batch variability when using TAS2R1 antibodies in longitudinal studies?

For consistent results in longitudinal studies using TAS2R1 antibodies:

• Antibody procurement and storage:

  • Purchase sufficient antibody from a single lot for the entire study duration

  • Prepare single-use aliquots to avoid repeated freeze-thaw cycles

  • Document lot numbers and maintain certificate of analysis records

• Reference standards development:

  • Create standardized positive control lysates in bulk

  • Aliquot and store at -80°C for use throughout the study

  • Include these reference standards in each experiment for normalization

• Protocol standardization:

  • Develop detailed SOPs for all antibody-based procedures

  • Use automated systems where possible to reduce operator variability

  • Standardize critical reagents (blocking solutions, buffers) and prepare in bulk

• Validation with multiple detection methods:

  • Correlate antibody-based detection with orthogonal methods (e.g., qRT-PCR)

  • Consider using multiple antibodies targeting different epitopes

  • Implement positive and negative controls in each experimental run

• Quantitative quality control:

  • Track signal-to-noise ratios across experimental batches

  • Implement statistical process control methods to identify drift

  • Consider including internal reference proteins for normalization

These approaches minimize technical variability, allowing more confident attribution of observed changes to biological factors rather than methodological inconsistencies.

How are TAS2R1 antibodies being utilized to investigate extra-oral functions of bitter taste receptors?

Recent research applications of TAS2R1 antibodies in extra-oral contexts include:

• Respiratory system studies:

  • Immunohistochemical localization of TAS2R1 in airway epithelial cells

  • Investigation of bitter taste receptor involvement in bronchodilation and anti-inflammatory responses

  • Analysis of receptor expression changes in respiratory diseases

• Gastrointestinal research:

  • TAS2R1 detection in enteroendocrine cells

  • Studies on receptor-mediated hormone release in response to bitter compounds

  • Investigation of gut-brain signaling pathways

• Immune cell investigations:

  • Detection of TAS2R in blood cells using RT-PCR and immunological methods

  • Analysis of TAS2R expression patterns in different leukocyte populations

  • Studies have confirmed the presence of taste receptors including TAS2R in various blood cells

• Reproductive system research:

  • Localization of TAS2R1 in testicular and ovarian tissues

  • Investigation of potential roles in gametogenesis and fertility

These investigations are revealing novel physiological roles for bitter taste receptors beyond their classical gustatory functions, potentially opening new therapeutic avenues for various diseases.

What advanced imaging techniques are being combined with TAS2R1 antibodies to study receptor dynamics and interactions?

Cutting-edge imaging approaches coupled with TAS2R1 antibodies include:

• Super-resolution microscopy:

  • STORM/PALM imaging to visualize receptor nanoclustering at resolutions below the diffraction limit

  • SIM for improved resolution of receptor distribution patterns in taste cells

• Live-cell imaging approaches:

  • FRAP (Fluorescence Recovery After Photobleaching) to study receptor mobility

  • Single-particle tracking of antibody-labeled receptors to analyze diffusion dynamics

  • FRET/BRET to investigate protein-protein interactions with signaling partners

• Correlative light and electron microscopy (CLEM):

  • Combining immunofluorescence with ultrastructural analysis

  • Provides context for receptor localization relative to cellular ultrastructure

• Advanced tissue clearing techniques:

  • CLARITY, iDISCO, or CUBIC clearing methods combined with immunolabeling

  • Allows 3D visualization of receptor distribution throughout intact tissues

• Multiplexed imaging:

  • Cyclic immunofluorescence or mass cytometry imaging

  • Enables simultaneous visualization of multiple bitter taste receptors and signaling components

These techniques provide unprecedented spatial and temporal resolution for understanding TAS2R1 biology in its native cellular context.

How can researchers leverage TAS2R1 antibodies to explore the relationship between genetic variations and receptor function?

Innovative approaches combining genetic analysis with antibody-based techniques include:

• Personalized cell models:

  • Generate induced pluripotent stem cells (iPSCs) from individuals with different TAS2R1 variants

  • Differentiate into relevant cell types (taste cells, enteroendocrine cells)

  • Use antibodies to assess receptor localization and expression levels

• CRISPR-engineered isogenic cell lines:

  • Introduce specific SNPs using genome editing

  • Compare wild-type and variant receptor trafficking and expression

  • Research has identified numerous SNPs with potential functional impacts on TAS2R receptors

• Structure-function correlation:

  • Map genetic variants to specific receptor domains

  • Use antibodies against different epitopes to assess conformational changes

  • Correlate with functional responses to bitter compounds

• Population-level immunophenotyping:

  • Analyze receptor expression patterns across individuals with different TAS2R1 genotypes

  • Link expression levels to taste perception phenotypes

  • Explore evolutionary aspects through cross-cultural comparisons

• Proteomics approaches:

  • Immunoprecipitation followed by mass spectrometry

  • Identify genotype-dependent differences in protein-protein interactions